Licensee Selection Process Sample Clauses

Licensee Selection Process. 3.1 Promptly after the Effective Date (and in any event within sixty (60) days of the Effective Date), MPP will identify proposed sublicensees who have: (A) demonstrated possession of adequate infrastructure and capabilities to enable the Sublicensee to distribute and supply Product to every country in the Territory under GDP; (B) production facilities operating under current Good Manufacturing Practice; (C) adequate, ESG, health and safety measures in place; (D) undergone and passed an anti-bribery and corruption assessment in accordance with agreed criteria for assessing anti-bribery and corruption to ensure compliance with applicable anti-corruption laws; and (E) undergone and passed export controls and trade compliance assessment in accordance with agreed criteria for assessing export controls and trade compliance. 3.2 During the Licensee Selection Process, MPP shall keep Novartis informed of the proposed Sublicensees and shall upon completion of the Licensee Selection Process promptly notify Novartis in writing of the entities MPP proposes to become the Sublicensees. Novartis shall within thirty (30) Calendar Days of such notification (acting reasonably) either approve or reject one or more of the proposed Sublicensees. For the avoidance of doubt if the proposed Sublicensee intends to use subcontractors including for supply of active ingredients, such subcontractor shall be approved by both MPP and Novartis as part of the Licensee Selection Process. 3.3 MPP shall not authorise or agree to any amendments to the terms of the Sublicence as set out in Schedule 1, whether before or after the execution of such Sublicence, without Novartis’s express prior consent in writing, signed by or on behalf of Novartis. 3.4 Novartis shall provide to any Sublicensee such consents which it has the legal capacity to give as are reasonably necessary to enable such Sublicensee to perform its obligations under the Sublicence.
Licensee Selection Process. ‌ 4.1 The MPPF will coordinate the Licensee Selection Process and the subsequent execution of a Sublicence between the MPPF and each Successful Applicant. 4.2 Promptly after the Effective Date (and in any event within ninety (90) days of the Effective Date), or pursuant to Clause 4.5 below, the MPPF will identify and notify ViiV of up to a maximum of three (3) Third Parties, each of which has: (A) demonstrated possession of, or demonstrated readiness to acquire, adequate infrastructure (operating under current Good Manufacturing Practice), technical capability, capacity, and willingness to (i) develop Licensed Compound and Licensed Product, and (ii) manufacture Licensed Product in a manner consistent with WHO pre-qualification standards or the standards of any regulatory authority which was a member or observer of the International Council on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (“ICH”), or associated with an ICH member through a legally-binding, mutual recognition agreement, in each case as before 23 October 2015; (B) demonstrated possession of adequate infrastructure to enable it to distribute and supply Licensed Product to the majority of the Territory; (C) provided a current EcoVadis report, or if the Third Party has no current report, has committed to obtaining such EcoVadis report as quickly as possible; and (D) in place a quick and efficient batch trace procedure following the GS1 Global Traceability or comparable standard, so as to enable the identification and location of Licensed Compound and Licensed Products from individual batches with minimal delay and the ability to implement upon request, collectively the “Selection Criteria”. At the same time, the MPPF shall provide documentary evidence, to ViiV’s satisfaction, that each proposed Third Party meets such Selection Criteria. 4.3 Within fifteen (15) Business Days of receipt by ViiV of satisfactory documentary evidence that such proposed Third Party meet the Selection Criteria, ViiV shall inform the MPPF in writing whether it agrees or disagrees that the Third Party proposed by the MPPF meet the Selection Criteria. In the event ViiV considers that the proposed Third Party has not satisfied the Selection Criteria, ViiV shall provide its reasons. In the event ViiV considers that the Third Party has satisfied the Selection Criteria, ViiV shall as soon as reasonably practicable undertake and complete any additional due diligence on such Third‌ Par...

Related to Licensee Selection Process

  • Selection Process The Mortgage Loans were selected from among the outstanding one- to four-family mortgage loans in the Seller's portfolio at the related Closing Date as to which the representations and warranties set forth in Subsection 9.02 could be made and such selection was not made in a manner so as to affect adversely the interests of the Purchaser;

  • Application Process The employees wishing to enter into a job share arrangement will apply in writing to the Employer and forward a copy to the Union outlining the proposed commencement date of the job share, how the hours and days of work will be shared and how communication and continuity of work will be maintained. The Employer shall communicate a decision on a job share request in writing to the applicants. Applications to Job Sharing shall not be unreasonably denied.

  • ONLINE PUBLIC AUCTION PROCESS Bidders may browse through the PAH Website and select the properties they wish to bid online.

  • Evaluation Process ‌ A. The immediate supervisor will meet with an employee at the start of their review period to discuss performance expectations. The employee will receive copies of their performance expectations as well as notification of any modifications made during the review period. Employee work performance will be evaluated during probationary, trial service and transition review periods and at least annually thereafter. Notification will be given to a probationary or trial service employee whose work performance is determined to be unsatisfactory. B. The supervisor will discuss the evaluation with the employee. The employee will have the opportunity to provide feedback on the evaluation. The discussion may include such topics as: 1. Reviewing the employee’s performance; 2. Identifying ways the employee may improve their performance; 3. Updating the employee’s position description, if necessary; 4. Identifying performance goals and expectations for the next appraisal period; and 5. Identifying employee training and development needs. C. The performance evaluation process will include, but not be limited to, a written performance evaluation on forms used by the Employer, the employee’s signature acknowledging receipt of the forms, and any comments by the employee. A copy of the performance evaluation will be provided to the employee at the time of the review. A copy of the final performance evaluation, including any employee or reviewer comments, will be provided to the employee. The original performance evaluation forms, including the employee’s comments, will be maintained in the employee’s personnel file. D. If an employee disagrees with their performance evaluation, the employee has the right to attach a rebuttal. E. The performance evaluation process is subject to the grievance procedure in Article 30. The specific content of a performance evaluation is not subject to the grievance procedure. F. Performance evaluations will not be used to initiate personnel actions such as transfer, promotion, or discipline.

  • Selection Procedure 10.2.4.1 Internal applicants shall be defined as all applicants with seniority in accordance with Article 12.5. 10.2.4.2 In filling a posted vacancy, first consideration shall be given to internal applicants who meet the stated qualifications. All Faculty members who meet the stated qualifications for the posted vacancy shall be interviewed by the Selection Committee. Past service and evaluations shall be considered by the Committee. The best qualified candidate shall be recommended for appointment to the position. 10.2.4.3 Where the qualifications of two or more of the applicants are relatively equal, the applicant with the greatest seniority shall be recommended for appointment to the position. 10.2.4.4 In establishing the qualifications, and in evaluating the qualifications and past performance of the applicants, the committee shall act in good faith, in a fair and reasonable manner, and shall not act in an arbitrary or discriminatory fashion. 10.2.4.5 Following the interviews, the committee will submit its recommendations containing a list of qualified candidates in order of preference, through the appropriate ▇▇▇▇ to the President or delegate. 10.2.4.6 New faculty members shall be appointed only when there are no qualified internal applicants. 10.2.4.7 If there are no qualified internal applicants, the selection committee may consider external applications, in accordance with the procedure outlined above. 10.2.4.8 Internal applicants will be advised as soon as possible of the selection committee's decision that the committee will be considering external applications in accordance with Article 10.2.4.7.